Journal of Asthma
Volume 53, 2016 - Issue 2
Open access
1,709
Views
4
CrossRef citations to date
0
Altmetric
Pharmacotherapy
Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma
Gordon RaphaelBethesda Allergy Asthma and Research Center, LLC, Bethesda, MD, USA, Correspondence[email protected]
, MD, Herminia TaverasTeva Pharmaceuticals, Miami, FL, USA and
, PhD, MPH, Harald IversonTeva Pharmaceuticals, Miami, FL, USA and
, PhD, Christopher O’BrienTeva Pharmaceuticals, Miami, FL, USA and
, MD, PhD & David MillerNortheast Medical Research Associates, North Dartmouth, MA, USA
, MD
Pages 187-193
|
Received 08 Apr 2015, Accepted 03 Jul 2015, Published online: 15 Sep 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.